Geneoscopy, a St. Louis-based biotech firm, announced Wednesday the closure of a $105 million Series C funding round, led by Bio-Rad Laboratories. The investment aims to accelerate the commercialization of ColoSense, the company's FDA-approved at-home colorectal cancer screening test. Through a strategic partnership with Labcorp, Geneoscopy plans to integrate ColoSense into comprehensive screening programs, making […]
Kevin Gitau is bizblip's Global News Technician. He is trained in our proprietary method of processing primary source interviews with AI products for news story compilation. From his home in Kenya, he's done contract work on several bizblip marketing projects since early 2021.
